dj Orthopedics Files Shelf Registration Statement on Behalf of Certain Selling Stockholders
SAN DIEGO, May 21 /PRNewswire-FirstCall/ -- dj Orthopedics, Inc., (NYSE: DJO), announced today that it has filed a shelf registration statement on Form S-3 with the United States Securities and Exchange Commission.
Once the shelf registration statement has been declared effective by the Securities and Exchange Commission, it will allow certain stockholders to sell, from time to time, up to 3,197,379 shares of dj Orthopedics' outstanding common stock. None of the shares covered by the registration statement will be sold by dj Orthopedics.
The selling stockholders are J.P. Morgan DJ Partners, LLC and J.P. Morgan Partners (23A SBIC), L.P., with respect to an aggregate of 3,072,379 of the shares being registered, and Les Cross, dj Orthopedics' President and CEO, with respect to the remaining 125,000 shares. Mr. Cross has indicated that he plans to use the majority of his after tax proceeds from sales of his shares being registered to repay in full his promissory notes due to dj Orthopedics for historical stock purchases in the approximate amount of $1.7 million, including accrued interest.
The registration statement relating to these securities has been filed with the Securities and Exchange Commission, but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. Any offer of these securities will be made solely by means of the prospectus included in the registration statement and any prospectus supplement that may be issued with respect to such offering.
About dj Orthopedics
dj Orthopedics is a global medical device company specializing in rehabilitation and regeneration products for the non-operative orthopedic and spine markets. The Company's broad range of over 600 rehabilitation products, including rigid knee braces, soft goods and pain management products, are used in the prevention of injury, in the treatment of chronic conditions and for recovery after surgery or injury. The Company's regeneration products consist of bone growth stimulation devices that are used to treat nonunion fractures and as an adjunct therapy after spinal fusion surgery.
The Company sells its products in the United States and in more than 30 other countries through networks of agents, distributors and its direct sales force that market its products to orthopedic and podiatric surgeons, spine surgeons, orthopedic and prosthetic centers, third-party distributors, hospitals, surgery centers, physical therapists, athletic trainers and other healthcare professionals. For additional information on the Company, please visit http://www.djoglobal.com.
SOURCE dj Orthopedics
-0- 05/21/2004
(DJO)
CO: dj Orthopedics
ST: California
IN: HEA MTC
SU:
ER-NT
-- LAF066 --
8425 05/21/2004 17:59 EDT http://www.prnewswire.com
dj Orthopedics, Inc.
Mark Francois, 760-734-4766
